Prostate Cancer Clinical Trial
Official title:
Study of Complementary Therapies in Men Receiving Radiation Therapy for Prostate Cancer: A Feasibility Trial
| Verified date | July 2017 |
| Source | Brigham and Women's Hospital |
| Contact | n/a |
| Is FDA regulated | No |
| Health authority | |
| Study type | Interventional |
Randomized clinical study of two CAM therapies, 1) Reiki and 2) Relaxation Response Therapy
with Cognitive Restructuring counseling (RRT with CR), compared to an education-only control
arm in patients about to begin an eight-week course of external beam radiotherapy (EBRx) for
prostate cancer.
Generally, we would like to examine the feasibility of studying Reiki and RRT with CR in
patients with prostate cancer, and to obtain preliminary results on the effectiveness of
these treatments compared to controls.
Specific objectives:
1. Determine the proportion of eligible patients who agree to participate in the study
2. Measure compliance with CAM therapy interventions
3. Measure compliance with physiologic and psychological outcome measurement assessments
4. Assess differences between experimental and control groups on measures on depression,
anxiety, quality of life, salivary cortisol levels and an immunomarkers
| Status | Completed |
| Enrollment | 60 |
| Est. completion date | June 15, 2017 |
| Est. primary completion date | June 15, 2017 |
| Accepts healthy volunteers | No |
| Gender | Male |
| Age group | 30 Years and older |
| Eligibility |
Inclusion Criteria: 1. Age > 30 2. Histologic documentation of prostate cancer (no time limit) 3. Gleason score assignment is mandatory prior to entry 4. ECOG Performance Status of 0, 1, or 2 5. Clinical Stage Tl - T4 adenocarcinoma of the prostate 6. Planned androgen suppression therapy prior to an eight-week course of external beam radiotherapy 7. Signed Informed Consent Exclusion Criteria: 1. Prior pelvic radiotherapy 2. Evidence of metastatic disease 3. Currently receiving ongoing psychotherapy or antidepressive medications 4. Non-English speaking |
| Country | Name | City | State |
|---|---|---|---|
| United States | Brigham and Women's Hospital | Boston | Massachusetts |
| Lead Sponsor | Collaborator |
|---|---|
| Brigham and Women's Hospital |
United States,
| Type | Measure | Description | Time frame | Safety issue |
|---|---|---|---|---|
| Primary | Obtain preliminary results on the effectiveness of these treatments compared to controls | QOL testing performed at four time points | Measurements taken at multiple time points |
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT05613023 -
A Trial of 5 Fraction Prostate SBRT Versus 5 Fraction Prostate and Pelvic Nodal SBRT
|
Phase 3 | |
| Recruiting |
NCT05540392 -
An Acupuncture Study for Prostate Cancer Survivors With Urinary Issues
|
Phase 1/Phase 2 | |
| Recruiting |
NCT05156424 -
A Comparison of Aerobic and Resistance Exercise to Counteract Treatment Side Effects in Men With Prostate Cancer
|
Phase 1/Phase 2 | |
| Completed |
NCT03177759 -
Living With Prostate Cancer (LPC)
|
||
| Completed |
NCT01331083 -
A Phase II Study of PX-866 in Patients With Recurrent or Metastatic Castration Resistant Prostate Cancer
|
Phase 2 | |
| Recruiting |
NCT05540782 -
A Study of Cognitive Health in Survivors of Prostate Cancer
|
||
| Active, not recruiting |
NCT04742361 -
Efficacy of [18F]PSMA-1007 PET/CT in Patients With Biochemial Recurrent Prostate Cancer
|
Phase 3 | |
| Completed |
NCT04400656 -
PROState Pathway Embedded Comparative Trial
|
||
| Completed |
NCT02282644 -
Individual Phenotype Analysis in Patients With Castration-Resistant Prostate Cancer With CellSearch® and Flow Cytometry
|
N/A | |
| Recruiting |
NCT06037954 -
A Study of Mental Health Care in People With Cancer
|
N/A | |
| Recruiting |
NCT06305832 -
Salvage Radiotherapy Combined With Androgen Deprivation Therapy (ADT) With or Without Rezvilutamide in the Treatment of Biochemical Recurrence After Radical Prostatectomy for Prostate Cancer
|
Phase 2 | |
| Recruiting |
NCT05761093 -
Patient and Physician Benefit/ Risk Preferences for Treatment of mPC in Hong Kong: a Discrete Choice Experiment
|
||
| Completed |
NCT04838626 -
Study of Diagnostic Performance of [18F]CTT1057 for PSMA-positive Tumors Detection
|
Phase 2/Phase 3 | |
| Recruiting |
NCT03101176 -
Multiparametric Ultrasound Imaging in Prostate Cancer
|
N/A | |
| Completed |
NCT03290417 -
Correlative Analysis of the Genomics of Vitamin D and Omega-3 Fatty Acid Intake in Prostate Cancer
|
N/A | |
| Completed |
NCT00341939 -
Retrospective Analysis of a Drug-Metabolizing Genotype in Cancer Patients and Correlation With Pharmacokinetic and Pharmacodynamics Data
|
||
| Completed |
NCT01497925 -
Ph 1 Trial of ADI-PEG 20 Plus Docetaxel in Solid Tumors With Emphasis on Prostate Cancer and Non-Small Cell Lung Cancer
|
Phase 1 | |
| Recruiting |
NCT03679819 -
Single-center Trial for the Validation of High-resolution Transrectal Ultrasound (Exact Imaging Scanner ExactVu) for the Detection of Prostate Cancer
|
||
| Completed |
NCT03554317 -
COMbination of Bipolar Androgen Therapy and Nivolumab
|
Phase 2 | |
| Completed |
NCT03271502 -
Effect of Anesthesia on Optic Nerve Sheath Diameter in Patients Undergoing Robot-assisted Laparoscopic Prostatectomy
|
N/A |